Want to see TSE:CHS full AI Analyst Report?
Top Page
Comprehensive Healthcare Systems Inc
(CHS)
Select Model
Select Model
Rating:45Neutral
Price Target:
C$0.43
▼(-25.17% Downside)
Action:Reiterated
Date:09/06/26
The score is primarily constrained by weak financial performance—large ongoing losses, negative equity, and worsening cash burn—despite strong recent revenue growth and healthy gross margins. Technicals are mixed (neutral RSI but negative MACD and price below longer-term averages), and valuation is limited by negative earnings (negative P/E) with no dividend yield provided.
Positive Factors
Revenue rebound
TTM revenue growth of 193% indicates a substantial rebound in demand and business activity. If sustained, this broader revenue base can improve operating leverage and provide a stronger platform for scaling the healthcare information-services offering over the next several quarters.
Negative Factors
Deep unprofitability
A net margin near negative 66% shows that strong revenue growth has not yet translated into viable bottom-line economics. Continued losses reduce internally generated capital, constrain reinvestment, and make a durable profitability turnaround dependent on substantial operating improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound
TTM revenue growth of 193% indicates a substantial rebound in demand and business activity. If sustained, this broader revenue base can improve operating leverage and provide a stronger platform for scaling the healthcare information-services offering over the next several quarters.
Read all positive factors
Comprehensive Healthcare Systems Inc (CHS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$12.90M
Dividend YieldN/A
Average Volume (3M)8.67K
Price to Earnings (P/E)―
Beta (1Y)-0.16
Revenue Growth7.63%
EPS Growth-106.03%
CountryCA
Employees47
SectorGeneral
Sector StrengthN/A
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.15
Shares Outstanding28,986,582
10 Day Avg. Volume6,174
30 Day Avg. Volume8,672
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)-0.95
Price to Sales (P/S)1.40
P/FCF Ratio-6.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Comprehensive Healthcare Systems Inc Business Overview & Revenue Model
Company Description
Comprehensive Healthcare Systems Inc. delivers bespoke administrative software solutions specifically tailored for the healthcare sector. Its comprehensive suite of services encompasses tools for membership card management, disease management prog...
Comprehensive Healthcare Systems Inc Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
18
Very Negative
Cash Flow
20
Very Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Sep 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.33M | 4.19M | 3.77M | 3.84M | 4.30M | 4.50M |
| Gross Profit | 2.34M | 2.37M | 2.06M | 1.15M | 1.40M | 1.37M |
| EBITDA | -2.20M | -1.10M | 121.99K | -2.86M | -5.13M | -2.63M |
| Net Income | -2.37M | -2.18M | -607.73K | -3.58M | -5.11M | -4.93M |
Balance Sheet | ||||||
| Total Assets | 2.59M | 925.61K | 652.20K | 964.56K | 2.11M | 4.11M |
| Cash, Cash Equivalents and Short-Term Investments | 1.41M | 39.88K | 7.67K | 23.75K | 542.64K | 3.40M |
| Total Debt | 2.37M | 2.67M | 2.50M | 2.47M | 1.96M | 1.76M |
| Total Liabilities | 4.85M | 7.13M | 7.08M | 6.79M | 5.26M | 3.50M |
| Stockholders Equity | -2.25M | -6.20M | -6.43M | -5.82M | -3.15M | 602.59K |
Cash Flow | ||||||
| Free Cash Flow | -2.69M | -900.62K | 36.31K | -1.23M | -4.04M | -3.28M |
| Operating Cash Flow | -2.37M | -723.57K | 366.80K | -1.23M | -3.97M | -3.27M |
| Investing Cash Flow | -92.47K | -97.80K | -628.01K | 0.00 | -68.41K | 215.14K |
| Financing Cash Flow | 3.79M | 854.22K | 245.07K | 852.45K | 1.04M | 4.39M |
Comprehensive Healthcare Systems Inc Technical Analysis
Neutral
0.58
Price Trends
0.45
Negative
0.54
Negative
0.58
Negative
Market Momentum
>-0.01
Negative
54.75
Neutral
30.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:CHS, the sentiment is Neutral. The current price of 0.58 is above the 20-day moving average (MA) of 0.41, above the 50-day MA of 0.45, and below the 200-day MA of 0.58, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 54.75 is Neutral, neither overbought nor oversold. The STOCH value of 30.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:CHS.
Comprehensive Healthcare Systems Inc Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$509.85M | 67.79 | 2.79% | ― | 53.79% | 29.92% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | C$57.20M | -11.50 | 9999.00% | ― | -36.92% | 13.03% | |
45 Neutral | C$12.90M | -1.99 | 64.52% | ― | 7.63% | -106.03% | |
45 Neutral | C$6.58M | -3.23 | 739.84% | ― | ― | -28.35% | |
44 Neutral | C$56.20M | -2.16 | -444.52% | ― | 415.06% | -54.80% | |
42 Neutral | C$11.23M | -3.24 | 6239.15% | ― | ― | 68.00% |
* General Sector Average
TSE:CHS
Comprehensive Healthcare Systems Inc
0.45
-0.05
-11.00%
TSE:ADK
Diagnos
0.48
0.21
82.69%
TSE:VHI
Vitalhub
8.04
-3.56
-30.69%
TSE:AIDR
Rocket Doctor AI
0.58
-0.14
-19.44%
TSE:UDOC
UniDoc Health Corp
0.13
-0.07
-35.00%
TSE:DMED
DiagnaMed Holdings Corp.
0.05
-0.04
-41.18%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.